This inventor holds 2 USPTO granted patents. Top assignee: National University of Singapore. Active years: 2013-2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013-2014
Title: Sanjiv Kumar Yadav: Innovator in Cancer Treatment
Introduction
Sanjiv Kumar Yadav is a prominent inventor based in Singapore, SG. He has made significant contributions to the field of cancer treatment through his innovative research and patented inventions. With a total of 2 patents, Yadav is recognized for his work in developing compounds that have the potential to improve therapeutic outcomes for patients.
Latest Patents
Yadav's latest patents include groundbreaking inventions that focus on the treatment of cancer and diabetes. The first patent, titled "Lanthanide metal complexes useful in treating cancer," relates to a compound of formula (I). This invention provides a method for killing cancer cells by administering the compound, as well as a method for treating cancer or diabetes in mammals using the same compound and its pharmaceutical compositions.
The second patent, "Metal triangulo compound and methods of using the same," involves metal triangulo compounds. This invention outlines methods for inducing apoptosis in cells and preventing carcinogenesis through the administration of these metal triangulo compounds.
Career Highlights
Sanjiv Kumar Yadav is affiliated with the National University of Singapore, where he conducts his research and development activities. His work is characterized by a strong focus on innovative solutions to complex medical challenges, particularly in oncology and metabolic diseases.
Collaborations
Yadav collaborates with notable colleagues, including Shazib Pervaiz and Alan Prem Kumar, who contribute to his research endeavors and help advance the field of cancer treatment.
Conclusion
Sanjiv Kumar Yadav is a dedicated inventor whose work in developing novel compounds for cancer treatment showcases his commitment to improving patient care. His contributions to the field are significant and continue to inspire further research and innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
